Tamura Yoshitaka, Ikeda Osama, Nakasone Yutaka, Shiraishi Shinya, Tomiguchi Seiji, Yamashita Yasuyuki, Takamori Hiroshi, Baba Hideo
Department of Diagnostic Radiology, Kumamoto University Graduate School of Medical and Pharmaceutical Sciences 1-1-1, Honjo Kumamoto 860-8505, Japan.
Acad Radiol. 2009 Jun;16(6):662-8. doi: 10.1016/j.acra.2008.12.004. Epub 2009 Mar 6.
We evaluated the effect of gravity on intrahepatic perfusion (IHP) in patients with a port-catheter system (PCS) implanted for hepatic arterial infusion chemotherapy (HAIC). Using fused single photon-emission computed tomographic (SPECT)/computed tomographic (CT) images, we compared IHP after the injection of technetium-99m-labeled macroaggregated albumin (Tc-99m-MAA) via a PCS with the patient in the upright and decubitus positions.
We enrolled 27 patients with metastatic carcinoma of the liver who bore an implantable PCS for HAIC. SPECT/CT images were obtained on the third and seventh postimplantation day; 99mTc-MAA (185 MBq) was delivered with the patient in the upright and decubitus positions. We selected four regions of interest (ROIs) on SPECT images of the superior, inferior, anterior, and posterior regions. The anteroposterior and the superoinferior perfusion ratio (AP ratio, SI ratio) were derived from the mean counts in each ROI. Using an unpaired t-test, we compared these ratios after drug delivery in the upright and decubitus injection positions. We also visually compared IHP and classified the distribution of drugs delivered in the upright and decubitus positions on fused images. Moreover, using World Health Organization criteria, we evaluated the therapeutic response by comparing the tumor size on contrast-enhanced CT images obtained before and 3 months after treatment.
The SI ratios in the upright and decubitus injection positions were 1.14 and 0.92, respectively; the corresponding AP ratios were 1.47 and 1.73, respectively, indicating that there was no significant difference in these parameters irrespective of the injection position (SI ratio: P = .27, AP ratio: P = .35). However, in 14 of the 27 patients (52%), the visual appearance of IHP was different in the upright and decubitus positions. A change in the location of the catheter side hole when the decubitus was changed to the upright position produced a difference in IHP. Of 13 patients with identical drug distribution in both injection positions, six (46%) manifested a partial response (PR), five (38%) experienced no change (NC), and two (15%) experienced progressive disease (PD). Among the 14 patients with different drug distribution in the two injection positions, four (28%) achieved PR, five (36%) manifested NC, and the other five (36%) had PD.
Although the patient posture affected IHP by changing the position of the infusion catheter side hole in the liver, gravity had no significant effect on IHP in patients bearing an implantable PCS for the delivery of HAIC.
我们评估了重力对植入经导管肝动脉灌注化疗(HAIC)的经皮肝穿刺导管系统(PCS)患者肝内灌注(IHP)的影响。使用融合单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)图像,我们比较了通过PCS在患者直立位和卧位注射99m锝标记的大颗粒白蛋白(Tc-99m-MAA)后的IHP。
我们纳入了27例患有肝转移癌且植入了用于HAIC的可植入PCS的患者。在植入后的第3天和第7天获得SPECT/CT图像;在患者直立位和卧位时注射99mTc-MAA(185MBq)。我们在SPECT图像上的上、下、前、后区域选择了四个感兴趣区(ROI)。前后灌注比和上下灌注比(AP比、SI比)由每个ROI中的平均计数得出。使用不成对t检验,我们比较了在直立位和卧位注射药物后这些比值。我们还直观地比较了IHP,并在融合图像上对直立位和卧位注射时药物的分布进行了分类。此外,使用世界卫生组织标准,我们通过比较治疗前和治疗后3个月获得的对比增强CT图像上的肿瘤大小来评估治疗反应。
直立位和卧位注射时的SI比分别为1.14和0.92;相应的AP比分别为1.47和1.73,表明无论注射位置如何,这些参数均无显著差异(SI比:P = 0.27,AP比:P = 0.35)。然而,在27例患者中的14例(52%)中,直立位和卧位时IHP的视觉表现不同。当卧位改为直立位时,导管侧孔位置的改变导致IHP出现差异。在两个注射位置药物分布相同的13例患者中,6例(46%)表现为部分缓解(PR),5例(38%)无变化(NC),2例(15%)疾病进展(PD)。在两个注射位置药物分布不同的14例患者中,4例(28%)达到PR,5例(36%)表现为NC,另外5例(36%)有PD。
尽管患者体位通过改变肝内输液导管侧孔的位置影响IHP,但重力对植入用于HAIC的可植入PCS的患者的IHP没有显著影响。